Somatic mutation in PIK3CA is a late event in cervical carcinogenesis

E-ISSN： 2056-4538|1|4|207-211

ISSN： 2056-4538

Source： The Journal Of Pathology: Clinical Research, Vol.1, Iss.4, 2015-10, pp. : 207-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer

By Woenckhaus Joachim Steger Klaus Sturm Klaus Münstedt Karsten Franke Folker Fenic Irina

Virchows Archiv, Vol. 450, Iss. 4, 2007-04 ,pp. : 387-395

Springer Publishing Company

Access to resources Recommend Favorite

Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas

By Lerma Enrique

Virchows Archiv, Vol. 453, Iss. 2, 2008-08 ,pp. : 133-139

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of PTEN loss and PIK3CA mutations and their correlation with efficacy of trastuzumab treatment in HER2-positive metastatic breast cancer: A retrospective study (KBC-SG 1001)

By Nishimura

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 47-52

Spandidos Publications

Access to resources Recommend Favorite

GSTP1 promoter hypermethylation is an early event in breast carcinogenesis

By Lee Ji

Virchows Archiv, Vol. 451, Iss. 3, 2007-09 ,pp. : 741-741

Springer Publishing Company

Access to resources Recommend Favorite

GSTP1 promoter hypermethylation is an early event in breast carcinogenesis

By Lee Ji

Virchows Archiv, Vol. 450, Iss. 6, 2007-06 ,pp. : 637-642

Springer Publishing Company

Access to resources Recommend Favorite